Sofiniclin

Sofinicline (ABT-894 ) is a novel nicotinic acetylcholine receptor agonist (nAChR) under development for the treatment of attention-deficit/hyperactivity disorder (ADHD).


Cat. No.: EX-A5733	Purity: >98%

	Chemical structure of Sofiniclin

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	800	In-stock
50mg	1300	In-stock
100mg	1950	In-stock
200mg	2850	In-stock
1g	4850	In-stock
5g	14500	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	ABT-894
CAS No.	799279-80-4
Purity	>98%
Formula	C10H11Cl2N3
Mol Weight	244.12
Color	White to light brown
State	solid powder
Solubility	Soluble in DMSO 35.71 mg/mL
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Zhang D, et al. ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Mov Disord. 2014 Apr;29(4):508-17. [2]. Zhang D, ET AL. α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage. Mov Disord. 2015 Dec;30(14):1901-11.
CoA	CoA of Sofiniclin


		Search